Psoriasis Updates: Joel Gelfand, MD, to Discuss the Rapidly Changing Landscape
On Tuesday, January 21, 2025, Joel Gelfand, MD, will join a panel of speakers to discuss the changing landscape of psoriasis and psoriatic arthritis.
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 1066 results for 'psoriasis'
Characterization of CLAP and CLAN Memory T Cells in Psoriasis
The following is a summary of “FC03 T17 polarization of skin-homing (CLA-positive) T cells is...
Read More
Characterization of Immune Cell Dynamics in Psoriasis Lesions
The following is a summary of “FC02 Immune cell signatures and T-cell receptor profiling reveal...
Read More
Tildrakizumab Demonstrates Long-term Benefits in Scalp Psoriasis Treatment
The following is a summary of “Efficacy and Safety of Tildrakizumab for the Treatment of...
Read More
Immune Biomarkers for Clinical Super-Response to Guselkumab in Psoriasis
The following is a summary of “FC01 Higher IL-10+ T-cell and Treg-cell counts in psoriatic skin...
Read More
Test Your Knowledge of Psoriasis Research Presented at Fall Clinical Dermatology Conference!
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2024? Test your knowledge now and see how you rank!
Read More
High Ultraprocessed Food Intake Linked to Active Psoriasis
TUESDAY, Dec. 3, 2024 (HealthDay News) — High ultraprocessed food (UPF) intake is associated...
Read More
Non-Pharmacological Strategies for Psoriasis Comorbidities: The Dermatologist’s Role
Amy Huang, MD, spoke with Physician’s Weekly about the non-pharmacologic options for managing comorbidities in patients with psoriasis.
Read More
Metabolic Dysfunction-Associated Liver Disease in Psoriasis
The following is a summary of “Identification of risk factors associated with metabolic...
Read MoreAdvertisement
Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study.
Evidence comparing the impact of various biologics for psoriasis on the progression to psoriatic arthritis (PsA) is limited. We therefore assessed the risk of PsA associated with interleukin (IL)-23 inhibitor, IL-17 inhibitor,...
Read More
JNJ-77242113 Demonstrates Sustained Skin Clearance in Psoriasis
The following is a summary of “FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of...
Read More
Comorbidities in Patients With Psoriasis: A Recap of Recent Research
Research presented at the Fall Clinical Dermatology 2024 and published in the literature highlights the extensive impact of comorbidities in psoriasis.
Read More
Long-term Effectiveness of Brodalumab in Treating Scalp and Nail Psoriasis
The following is a summary of “Brodalumab is Effective for Psoriasis Patients with...
Read More
Role of Cardiometabolic Risk in Psoriasis-Associated Comorbidities
The following is a summary of “Multicomorbidity in Psoriasis Vulgaris: A Retrospective Analysis,”...
Read More
CME/CE: How Often Should You Screen for CV Comorbidities in Patients With Plaque Psoriasis?
This course discusses a review that provides guidance for cardiovascular disease screening type...
Read More
Psoriasis, Other Comorbidities Impact Development of Latent Autoimmune Diabetes in Adults
Patients with autoimmune diseases, including psoriasis, are at higher risk for being diagnosed with latent autoimmune diabetes in adults, or LADA.
Read More
Commentary Examines “Provocative Thinking” About a Psoriasis Cure
In a commentary for the Journal of Investigative Dermatology, Joel M. Gelfand, MD, discusses psoriasis treatment, recent advances, and the potential for a cure.
Read More
“Polyclonal Parapsoriasis en Plaque” Lesions Represent Distinct Parapsoriasis Disease Entity
The following is a summary of “Single cell sequencing delineates T-cell clonality and pathogenesis...
Read More
Potential Drug Targets and Pathways in the Pathogenesis of Psoriasis
The following is a summary of “Single-Cell Sequencing Combined with Transcriptome Sequencing to...
Read More
Clinical and Psychological Predictors of Satisfaction in Psoriasis Care
The following is a summary of “Residual disease is the main, but not the only factor impacting...
Read More